Aussie biotech stocks tend to do fairly badly compared to the rest of the ASX.
Unless you know what you're doing it's often better to day trade Aussie biotech stocks (I was originally going to sell on open today - but sadly changed my mind).
We will see where this ends up but it'll predictably drift down for a bit imo (see Imugene whose tech I really like, but keeps drifting down).
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica, page-134
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
